Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A government funding lapse notice now appears on the page, stating that information may not be up to date. The site version was updated to Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:18:19.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and a new 'Revision: v3.4.0' label; minor metadata updates include capitalization changes for labels and removal of older entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:01:15.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    - Page revision label updated from v3.3.3 to v3.3.4. This appears to be a versioning update and does not alter the study content on the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:28:41.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new Locations section appears for the Philadelphia, PA site under Pennsylvania, replacing the old Pennsylvania Locations entry. The footer revision has been updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:34.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate entries are automatically filled from PubMed, and the page revision updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:35:32.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Removed a general government funding/status notice that previously warned about possible updates and NIH operating status. This notice did not pertain to the study details, eligibility, or results on the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.